Safety
Bridion and the Tale of Two Agencies
Once upon a time, there was a promising new drug named Bridion. It was touted by its manufacturer as the first major pharmaceutical advance in the field of anesthesia in two decades. The drug was submitted to two powerful health authorities for marketing approval. Authorization looked like a foregone conclusion as advisory committees for both [...]
Speaking of Vaccinations…
In February, I posted an article about the increasing amounts of research being done with the Measles, Mumps and Rubella (MMR) vaccinations and how there is an increasing number of studies being done that disprove the vaccination’s link to autism. In it, I gave a little history on Andrew Wakefield, the British scientist who [...]
NanoGuardian: Ensuring the Your Medicine is Safe
I was packaged April 28, 2008, in Puerto Rico. My Batch Number is AA6-73P008. I will expire on January 15, 2012. I am associated with 2-D barcode KBDCHDH1528. I was packaged for distribution in Canada. I can tell you as much information as you design me [...]
Pharmaceutical start-ups: Phytomedics
I read today about a really interesting pharmaceutical company that, though it’s considered a start-up, has spent the last 12 years researching and developing new drugs and methodologies that will allow for more rapid and safer development of drug products: Phytomedics. Their focus is on botanical drugs, which, in theory, could provide many of [...]
The Agonist/Antagonist Duel for Enhanced Pharmaceuticals
This is the first posting from Scott Alexander. For more information about Scott, click the Author link on this page.
One of the persistent challenges of the Pharmaceutical industry has been maintaining the safety and efficacy of drug products in patients over time. In other words, when a patient starts taking the drug, the patient [...]
